Perimenopause and Heart Disease Risk: What Every Woman Needs to Know
How oestrogen decline raises cardiovascular risk during perimenopause. Practical steps to protect your heart through lifestyle, monitoring, and medical care.
Why Cardiovascular Risk Rises During Perimenopause
Before perimenopause, women have significantly lower rates of heart disease than men of the same age. Oestrogen provides meaningful cardiovascular protection: it keeps LDL cholesterol lower, HDL cholesterol higher, reduces arterial inflammation, improves endothelial function (the health of blood vessel linings), and helps maintain flexible, responsive arteries. As oestrogen declines through perimenopause, these protective effects diminish. Cholesterol profiles often worsen. Blood pressure rises. Arterial stiffness increases. Visceral fat, which is metabolically active and pro-inflammatory, accumulates around the abdomen. Insulin resistance becomes more common. Each of these changes individually raises cardiovascular risk, and in perimenopause they tend to cluster together, compounding the effect. Research shows that the rate of cardiovascular risk escalation in women during the menopausal transition is steeper than in men of comparable age. This is not a reason for alarm, but it is a compelling reason to take cardiovascular health seriously during your 40s and early 50s.
Understanding Your Cholesterol Numbers After 40
Many women are surprised to find that their cholesterol results worsen significantly during perimenopause, even without changes to diet or exercise. This is a direct consequence of oestrogen loss affecting how the liver processes lipoproteins. Total cholesterol rises, LDL (the atherogenic particle that deposits in artery walls) increases, and in some women HDL (the protective particle) falls. Triglycerides may also rise, particularly in women who are gaining weight or experiencing increasing insulin resistance. If your last cholesterol test was before perimenopause began, it may no longer reflect your current risk. Ask your GP for a full fasting lipid panel if you have not had one recently. The result should be interpreted in the context of your overall cardiovascular risk score rather than as isolated numbers. Women with elevated LDL or worsening lipid profiles during perimenopause benefit from dietary changes, particularly reducing saturated fat and increasing soluble fibre, and should discuss whether medication is appropriate.
Blood Pressure: The Silent Risk Factor
Blood pressure tends to rise during perimenopause for several reasons. Oestrogen helps relax blood vessel walls and reduces vascular resistance, so its decline leads to increased arterial tone. Weight gain, reduced sleep quality, and higher stress levels, all common during this transition, further elevate blood pressure. Many women who had comfortably normal blood pressure in their 30s develop stage 1 or stage 2 hypertension during their 40s and early 50s. Hypertension is a major modifiable risk factor for heart attack and stroke, and it is easily missed because it produces no symptoms. Home blood pressure monitoring is a practical and low-cost way to track your readings between GP appointments. If you consistently record readings above 130/80 mmHg at home, this warrants investigation and discussion with your doctor. Lifestyle changes including reducing sodium, increasing potassium from fruit and vegetables, regular aerobic exercise, and limiting alcohol can meaningfully lower blood pressure. Medication is effective and appropriate when lifestyle measures are insufficient.
Heart Palpitations During Perimenopause
Heart palpitations are among the most anxiety-provoking perimenopausal symptoms. Women often describe the sensation as a racing heart, a fluttering in the chest, or a feeling that the heart has skipped a beat. In the majority of cases, perimenopausal palpitations are benign and linked to autonomic nervous system changes driven by oestrogen fluctuations. However, not all palpitations during perimenopause are hormonally driven, and some warrant investigation. Palpitations that are frequent, prolonged, accompanied by dizziness, shortness of breath, or chest pain, or that occur at rest rather than during exertion or emotional stress, should be assessed by a doctor. An ECG and possibly a 24-hour Holter monitor can identify whether an underlying arrhythmia is present. For most women, palpitations improve with HRT as hormone levels stabilise, reduced caffeine and alcohol intake, improved sleep, and stress management techniques. It is worth getting them checked rather than assuming they are always hormonal.
Lifestyle Strategies to Protect Your Heart
Cardiovascular disease is largely preventable through modifiable lifestyle factors, and perimenopause is an ideal time to invest in these habits before risk has fully escalated. Regular aerobic exercise is the single most evidence-based cardiovascular protective strategy. Aim for at least 150 minutes per week of moderate-intensity activity such as brisk walking, cycling, or swimming, combined with two strength training sessions per week. Strength training improves insulin sensitivity, supports healthy body composition, and benefits bone density alongside cardiovascular health. Diet quality matters substantially: the Mediterranean dietary pattern, emphasising vegetables, legumes, wholegrains, olive oil, oily fish, and nuts, is associated with lower cardiovascular disease risk in peri and post-menopausal women. Smoking cessation is essential because smoking removes most of the cardiovascular advantage women hold over men. Alcohol intake above low-risk guidelines raises blood pressure and triglycerides. Sleep quality is increasingly recognised as a cardiovascular risk factor in its own right, making sleep optimisation a genuine heart health intervention.
When to See a Cardiologist
Your GP can manage most cardiovascular risk factors during perimenopause through standard monitoring, lifestyle counselling, and medication where needed. A cardiology referral becomes appropriate in certain circumstances. If you have a strong family history of early heart disease, particularly a parent or sibling with a heart attack or stroke before age 60, a cardiology assessment for baseline risk stratification is reasonable. If your blood pressure remains uncontrolled on two or more medications, a specialist review is warranted. If you experience symptoms such as chest tightness, breathlessness on mild exertion, or palpitations with associated symptoms, prompt cardiac assessment is essential. Women with pre-existing cardiac conditions such as congenital heart disease, cardiomyopathy, or prior arrhythmias should discuss how perimenopause might affect their condition directly with their cardiologist. HRT decisions in women with cardiovascular risk factors are nuanced. Evidence increasingly supports early initiation of HRT, before age 60 and within 10 years of menopause, as cardiovascular neutral or beneficial in healthy women, though this should be discussed individually with your clinical team.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.